Chem-fig (Bup HCl Chem Fig)
Chemical structure of Buprenorphine hydrochloride, showing its molecular arrangement with distinct functional groups and bonds.*
Buprenorphine Hcl Tablet
Product Images NDC 70518-2014
6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 70518-2014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ifu-image (Ifu Image)
An instructional illustration showing a person placing a sublingual tablet under their tongue, demonstrating the proper administration method for buprenorphine HCl tablets.*
Mm1 (Buprenorphine 8mg 70518 2014 00)
Label for Buprenorphine Sublingual Tablet C-II, 8 mg strength, containing 30 tablets. The label includes NDC number 70518-2014-00 and shows it is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Hikma Pharmaceuticals USA, Inc., Eatontown, NJ. Storage instructions and federal law caution are visible.*
Mm2 (Buprenorphine 8mg 70518 2014 01)
Label for Buprenorphine sublingual tablets, 8 mg strength, packaged in a quantity of 60 tablets. The label includes NDC 70518-2014-01, indicates the drug is Schedule C-III, and is labeled for prescription use only. Manufactured by Hikma Pharmaceuticals USA, repackaged by RemedyRepack Inc., with storage and caution instructions included.*
Mm3 (Buprenorphine 8mg 70518 2014 02)
Box label for Buprenorphine Sublingual Tablet C-III, 8 mg strength, containing 100 tablets per box. Label shows product NDC 70518-2014-02, repackaged by RemedyRepack Inc., Indiana, PA. Includes federal caution about drug transfer and storage instructions.*
Mm4 (Buprenorphine 8mg 70518 2014 03)
The label for Buprenorphine Sublingual Tablet, 8 mg, single tablet package. The product is labeled as a Schedule III controlled substance. It is repackaged by RemedyRepack Inc. The label includes storage instructions, caution about federal law restricting drug transfer, and manufacturer information for Hikma Pharmaceuticals USA Inc., Eatontown, NJ.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
